Danger in treating cardiac patients with stem cells – San Diego Jewish World
|
Danger in treating cardiac patients with stem cells
San Diego Jewish World TEL AVIV (Press Release) — Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and “miraculous” stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may … |
The Hill |
Stem cell scientist joins crowded field to unseat Rohrabacher
The Hill Stem cell researcher Hans Keirstead is the latest Democrat to jump into the race to unseat longtime Rep. Dana Rohrabacher (R) in one of California’s top swing seats. Keirstead announced his bid on Thursday, touting a career in medicine and saying he … Stem–cell pioneer Hans Keirstead to challenge Rep. Dana RohrabacherOCRegister |
Science Magazine |
Texas has sanctioned unapproved stem cell therapies. Will it change anything?
Science Magazine Texas Governor Greg Abbott yesterday signed a bill allowing clinics and companies in the state to offer people unproven stem cell interventions without the testing and approval required under federal law. Like the “right to try” laws that have sprung … |
|
PD-L2 Adds Value to Immunotherapy Prediction in Head and Neck Cancers, Merck Study Finds
GenomeWeb NEW YORK (GenomeWeb) – A new study in Clinical Cancer Research has shown that certain cancer patients with altered PD-L2 expression may do better when treated with PD-1 targeting immunotherapy regardless of their levels of PD-L1, which is the … |
Genetic Engineering & Biotechnology News |
PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer
Genetic Engineering & Biotechnology News Immunotherapy has ignited a firestorm of interest from scientists to the media, as many of the therapeutic compounds in this class have proven successful at combating disease like cancer when many other drugs have failed. Much of immunotherapy research … |